Search results
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 1 day agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express ...
EU regulators approve BeiGene's tislelizumab for lung cancer (NASDAQ:BGNE)
Seeking Alpha· 2 days agoEU regulators have approved BeiGene’s (NASDAQ:BGNE) tislelizumab for the treatment of three types of...
Tongue Cancer: Everything You Need to Know
Verywell Health via Yahoo News· 3 days agoTongue cancer, a type of oral cancer, often begins as a painful lump or sore on the side of the tongue that may bleed and resist healing. Here’s what to...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 17 hours agoBladder cancer and renal cell carcinoma are big opportunities, Issi said, with between 82,000 to...
EU approves BeiGene's tislelizumab for lung cancer By Investing.com
Investing.com· 2 days agoThe European Commission (EC) has granted approval to tislelizumab for the treatment of non-small...
The Cancer Screenings Every Young Woman Should Get
The Oprah Magazine via Yahoo News· 3 days ago“Most of the time, it’s not due to colorectal cancer, but it should always be evaluated,” she says. Skin cancer screening The most common types of cancer...
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 19 hours agoIn January, Roche terminated the collaboration and licensing agreement for HOOKIPA’s HB-700 program...
What Is Pancreatic Cancer?
Health via Yahoo News· 3 days agoOther types of exocrine tumors are less common but include: Acinar cell carcinomas Undifferentiated carcinomas Adenosquamous carcinomas Squamous cell <...
Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors
Medscape· 1 week agoReports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 10 hours agoShanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
